Cellectar Biosciences, Inc.
CLRBW
CLRBW was delisted on the 20th of August, 2019.
2 hedge funds and large institutions have $47K invested in Cellectar Biosciences, Inc. in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$198K |
| 2 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$968 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $47K | +$198K | +65,362 | New |
|
|
2
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | +$968 | +320 | New |
|
CLRBW Hedge Fund Activity: Q1 2016 in Review
2 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. (CLRBW) for Q1 2016, worth a combined $47K.
Buyers outnumbered sellers: 2 funds opened new CLRBW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $198K.
- 2 institutional investors held Cellectar Biosciences, Inc. (CLRBW) as of Q1 2016, up from 0 in Q4 2015.
- Funds reported $47K of Cellectar Biosciences, Inc. stock for Q1 2016.
- 2 funds opened new Cellectar Biosciences, Inc. positions in Q1 2016 and 0 closed out, a net change of +2 holders.
- The largest Cellectar Biosciences, Inc. buyer in Q1 2016 was Sabby Management, an estimated $198K added.
Based on aggregated 13F filings for Q1 2016.